Advertisement

Related Videos

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Amit Sanyal, MD: A Clinician’s Perspective

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Advertisement

Advertisement




Nov
03
Today In Oncology
Hypofractionated Postmastectomy Radiotherapy With Internal Mammary Node Irradiation Demonstrates Noninferior Locoregional Control
Neoadjuvant Niraparib Shows Activity in HRD-Positive Advanced Ovarian Cancer
HER2-Positive Targeted Therapy Cardiovascular Risk: ACC Upcoming Journal Club
A Fraction of the Fractions: SBRT Before Pancreatic Cancer Surgery
Researchers Explore Potential Strategy for Overcoming Resistance to RAS Inhibitors
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo